BackTaiMed Biologics Overview

TaiMed Biologics Total Liabilities

TaiMed Biologics's total liabilities is $820M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$824.49M
↓ 6.20% YoYΔ $-54.47M vs prior year quarter

Peer trimmed avg / median

Loading

TaiMed Biologics Total Liabilities History

Loading

TaiMed Biologics vs. peers: Total Liabilities Comparison

Loading

TaiMed Biologics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

TaiMed Biologics (4147.TWO) FAQ

As of the most recent data (June 2026), 4147.TWO shows a total liabilities of $820M. That compares with $880M in the prior-year period — down 6.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4147.TWO's total liabilities is now $820M (was $880M) — a 6.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether TaiMed Biologics is outperforming or lagging.

Tracking 4147.TWO's total liabilities over time shows whether TaiMed Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $820M That compares with $880M in the prior-year period — down 6.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has TaiMed Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $820M) with ownership activity and broader fundamentals.

TaiMed Biologics's total liabilities is $820M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.